This study provides evidence that persistent elevation in CRP is associated with increased risk of hospitalization for HF (HFH) and HF-related mortality in long-term (~6-year) follow-up for a population with acute STEMI receiving early successful PCI and guideline-based therapies. This evidence concerns the gene CRP and hydrops fetalis.